Pliant Therapeutics Inc
NASDAQ:PLRX
Pliant Therapeutics Inc
NASDAQ:PLRX
Price:
1.18
USD
8.26%
Market Closed
Market Cap:
$72.5m
Balance Sheet
Balance Sheet Decomposition
Pliant Therapeutics Inc
Pliant Therapeutics Inc
Balance Sheet Decomposition is not available for
Pliant Therapeutics Inc
Pliant Therapeutics Inc
Balance Sheet
Pliant Therapeutics Inc
Pliant Therapeutics Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
4
|
61
|
86
|
51
|
52
|
34
|
63
|
71
|
|
| Cash Equivalents |
4
|
61
|
86
|
51
|
52
|
34
|
63
|
71
|
|
| Short-Term Investments |
0
|
0
|
17
|
226
|
149
|
298
|
431
|
285
|
|
| Total Receivables |
0
|
1
|
7
|
9
|
2
|
2
|
3
|
2
|
|
| Accounts Receivables |
0
|
0
|
7
|
9
|
2
|
2
|
0
|
0
|
|
| Other Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
5
|
7
|
7
|
8
|
4
|
|
| Total Current Assets |
5
|
62
|
112
|
291
|
209
|
340
|
506
|
362
|
|
| PP&E Net |
2
|
4
|
4
|
4
|
11
|
10
|
5
|
33
|
|
| PP&E Gross |
2
|
4
|
4
|
4
|
11
|
10
|
5
|
33
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
4
|
5
|
7
|
9
|
11
|
|
| Other Long-Term Assets |
0
|
1
|
3
|
1
|
1
|
0
|
2
|
2
|
|
| Total Assets |
7
N/A
|
67
+908%
|
119
+79%
|
296
+148%
|
221
-25%
|
351
+58%
|
512
+46%
|
397
-22%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
3
|
1
|
2
|
3
|
2
|
5
|
6
|
|
| Accrued Liabilities |
2
|
3
|
7
|
10
|
14
|
22
|
24
|
27
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
5
|
8
|
12
|
17
|
24
|
29
|
33
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
10
|
10
|
30
|
|
| Other Liabilities |
0
|
1
|
1
|
1
|
5
|
3
|
0
|
29
|
|
| Total Liabilities |
3
N/A
|
6
+84%
|
9
+54%
|
13
+37%
|
22
+78%
|
37
+68%
|
39
+3%
|
93
+141%
|
|
| Equity | |||||||||
| Common Stock |
40
|
132
|
186
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
37
|
72
|
76
|
118
|
215
|
338
|
500
|
710
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
401
|
414
|
654
|
973
|
1 014
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Equity |
3
N/A
|
61
+1 736%
|
110
+82%
|
283
+157%
|
199
-30%
|
313
+57%
|
474
+51%
|
304
-36%
|
|
| Total Liabilities & Equity |
7
N/A
|
67
+908%
|
119
+79%
|
296
+148%
|
221
-25%
|
351
+58%
|
512
+46%
|
397
-22%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
34
|
34
|
34
|
36
|
36
|
49
|
60
|
61
|
|
Switch to:
Switch to:
See Also
Discover More
